Unique ID issued by UMIN | UMIN000037200 |
---|---|
Receipt number | R000042408 |
Scientific Title | A study to investigate the efficacy and dose response of Euglena by questionnaires for a measure of the subjective well-being |
Date of disclosure of the study information | 2019/07/03 |
Last modified on | 2019/11/13 17:11:14 |
A study to investigate the efficacy and dose response of Euglena by questionnaires for a measure of the subjective well-being
A study to investigate the efficacy and dose response of Euglena by questionnaires for a measure of the subjective well-being
A study to investigate the efficacy and dose response of Euglena by questionnaires for a measure of the subjective well-being
A study to investigate the efficacy and dose response of Euglena by questionnaires for a measure of the subjective well-being
Japan |
Healthy individuals
Not applicable | Adult |
Others
NO
The aim of this study is to evaluate the dose response of Euglena for improving subjective well-being depending on the amount of Euglena intake.
Safety,Efficacy
Not applicable
Questionnaires for subjective
well-being or other QOL scales
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Dose comparison
YES
NO
No need to know
7
Prevention
Food |
Ingestion of study food (containing related ingredients 500mg ) for 4 weeks
Ingestion of study food (containing related ingredients 700mg ) for 4 weeks
Ingestion of study food (containing related ingredients 1,000mg ) for 4 weeks
Ingestion of study food (containing related ingredients 1,500mg ) for 4 weeks
Ingestion of study food (containing related ingredients 2,000mg ) for 4 weeks
Ingestion of study food (containing related ingredients 3,000mg ) for 4 weeks
Ingestion of control food substance for 4 weeks
20 | years-old | <= |
65 | years-old | > |
Male and Female
1)Subjects of both sexes above 20 years old- under 65 years old
2)Subjects who can answer on line questionnaires by smartphone or iPhone
3)Subjects who give consent
1)Subjects who are under pharmacological treatment for chronic disorders, especially subjects who take Warfarin
2)Subjects who have histories of mental disorders (Depression etc.)
3)Subjects work irregular hours on the night shift or irregular shift
4)Subjects who had participated in other clinical trials or monitoring studies within 1 month
5)Subjects who have intolerance to study food substance
6)Subjects who are in pregnancy, lactation, or who are willing to become pregnant
7)Subjects who are ineligible due to the chief inspector's judgment
210
1st name | Ayaka |
Middle name | |
Last name | Nakashima |
euglena Co., Ltd.
Advanced Technology Research Department Functionality Research Section
108-0014
Shiba 5-29-11 Minato-ku, Toyko 108-0014, Japan
03-3453-4907
nakashima@euglena.jp
1st name | shigeru |
Middle name | |
Last name | imai |
Leverage Brain Inc.
Clinical Trial Department
153-0053
Gohongi 3-13-16 Meguro-ku, Tokyo 153-0053, Japan
08072900404
https://www.levbrain.com
imai@levbrain.com
Leverage Brain Inc.
euglena Co., Ltd.
Profit organization
Japan
Japan Conference of Clinical Research
2-27-17 Minamiikebukuro Toshima-ku, Tokyo, Japan
0368687022
jccr-info@cts-smo.com
NO
2019 | Year | 07 | Month | 03 | Day |
Unpublished
Completed
2019 | Year | 06 | Month | 03 | Day |
2019 | Year | 06 | Month | 14 | Day |
2019 | Year | 07 | Month | 03 | Day |
2019 | Year | 09 | Month | 30 | Day |
2019 | Year | 10 | Month | 10 | Day |
2019 | Year | 10 | Month | 15 | Day |
2019 | Year | 10 | Month | 31 | Day |
2019 | Year | 06 | Month | 27 | Day |
2019 | Year | 11 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042408